1Six I, Okazaki H, Gross P, et al. Direct, acute effects of Klotho and Fgf23 on vascular smooth muscle and endothelium[J]. PLoS One, 2014, 9(4): e93423.
2Lim K, Lu TS, Molostvov G, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23[J]. Circulation, 2012, 125(18): 2243-2255.
3Hsu SC, Huang SM, Lin SH, et al. Testosterone increases renal anti- aging Klotho gene expression via the androgen receptor- mediated pathway[J]. Biochem J, 2014(464): 221-229.
4Hu MC, Shi M, Zhang J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease[J]. J Am Soc Nephrol, 2011(22): 124-136.
5Tangri N, Alam A, Wooten EC, et al. Lack of association of Klotho gene variants with valvular and vascular calcification in caucasians: A candidate gene study of the Framingham Offspring Cohort[J]. Nephrol Dial Transplant, 2011(26): 3998- 4002.
6Seialla J J, Lau WL, Reilly MP, et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification[J]. Kidney Int, 2013(83): 1159-1168.
7Moe SM, Drueke T, Lameire N, et aL Chronic kidney disease- mineral- bone disorder: A new paradigm[J]. Adv Chronic Kidney Dis, 2007(14): 3-12.
8Nikolov IG, Joki N, Nguyen- Khoa T, et al. Chronic didney disease bone and mineral disorder (Ckd - Mbd) in apofipoprotein e- deficient mice with chronic renal failure[J]. Bone, 2010(47): 156-163.
9Taylor J, Butcher M, Zeadin M, et al. Oxidized low- density lipoprotein promotes osteoblast differentiation in primary cultures of vascular smooth muscle cells by up- regulating osterix expression in an Msx2- dependent manner[J]. J Cell Biochem, 2011(112): 581-588.
10Ohnishi M, Nakatani T, Lanske B, et al. In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin D levels[J]. Cire Cardiovasc Genet, 2009(2): 583-590.
